Video 16 Oct 2019 Australia’s Orthocell ready to file on interim Celgro™ data BioWorld has reported on Orthocell's plans to seek early FDA approval for our Celgro™ nerve regeneration treatment, following positive interim… Orthocell
Video 08 May 2019 Orthocell unveils first clinical trial results for nerve regeneration platform CelGro Early results from Orthocell's nerve regeneration study have been featured in Small Caps. Read the article HERE. Orthocell
Video 13 Feb 2019 Orthocell hails high success rate for tendon injury treatment Small Caps has featured the results from Orthocell's recent study that shows an 82% success rate using its novel stem… Orthocell
Company News, Video 26 Oct 2018 Patient Story | Back To Full Stride With Orthocell’s Ortho-ATI™ Therapy For 34-year-old Daniel Kerr, sport is life. The talented Perth-born Australian rules footballer, best known for playing 220 games for… Orthocell
Media, Video 26 Oct 2018 Channel 7 | Ortho-ATI™ Feature Story Channel 7 News Perth has showcased Orthocell’s successful tendon treatment therapy for AFL star Daniel Kerr. Orthocell
Media, Video 30 Jun 2018 Video | Channel 9 News Report – Ortho-ATI™ – June 2018 Channel 9 News has featured Orthocell's Ortho-ATI™ as part of its nightly news coverage. Orthocell
Video 31 Jan 2018 Orthocell secures Canadian patent rights for tendon regeneration News that Orthocell has been granted a key Canadian patent for our Ortho-ATI product has been published in Small Caps. Orthocell
Media, Video 13 Dec 2017 Video | CommSec Interview – December 2017 Orthcell CEO and Managing Director, Paul Anderson, speaks with CommSec's Tom Piotrowski about the company’s two key products, its recently… Orthocell
Media, Video 05 Jan 2016 Video | AusBiotech Interview – January 2016 Orthocell CEO & Managing Director, Paul Anderson, explains the unique technology behind the company's cellular regenerative medicine, and in particular… Orthocell
